What is the evidence for systemic effects of intravitreal anti-VEGF agents, and should we be concerned?

por Avery, Robert L
Publicado 2014

Progression to macula-off tractional retinal detachment after a contralateral intraoperative intravitreal bevacizumab injection for proliferative diabetic retinopathy

por Zlotcavitch, Leonid, Flynn, Harry W, Avery, Robert L, Rachitskaya, Aleksandra
Publicado 2015

Aflibercept Does Not Suppress Angiopoietin-2 in Patients With nAMD or DME

por Avery, Robert L., Csaky, Karl G., Westenskow, Peter, Stoilov, Ivaylo, Diack, Cheikh
Publicado 2023

A prospective pilot study comparing combined intravitreal ranibizumab and half-fluence photodynamic therapy with ranibizumab monotherapy in the treatment of neovascular age-related...

por Williams, Patrick D, Callanan, David, Solley, Wayne, Avery, Robert L, Pieramici, Dante J, Aaberg, Tom
Publicado 2012

Systemic pharmacokinetics following intravitreal injections of ranibizumab, bevacizumab or aflibercept in patients with neovascular AMD

por Avery, Robert L, Castellarin, Alessandro A, Steinle, Nathan C, Dhoot, Dilsher S, Pieramici, Dante Joseph, See, Robert, Couvillion, Stephen, Nasir, Ma'an A, Rabena, Melvin D, Le, Kha, Maia, Mauricio, Visich, Jennifer E
Publicado 2014

SYSTEMIC PHARMACOKINETICS AND PHARMACODYNAMICS OF INTRAVITREAL AFLIBERCEPT, BEVACIZUMAB, AND RANIBIZUMAB

por Avery, Robert L., Castellarin, Alessandro A., Steinle, Nathan C., Dhoot, Dilsher S., Pieramici, Dante J., See, Robert, Couvillion, Stephen, Nasir, Ma'an A., Rabena, Melvin D., Maia, Mauricio, Van Everen, Sherri, Le, Kha, Hanley, William D.
Publicado 2017

The real-world efficacy and safety of faricimab in neovascular age-related macular degeneration: the TRUCKEE study – 6 month results

por Khanani, Arshad M., Aziz, Aamir A., Khan, Hannah, Gupta, Ashwin, Mojumder, Ohidul, Saulebayeva, Aigerim, Abbey, Ashkan M., Almeida, David R. P., Avery, Robert L., Banda, Himanshu K., Barakat, Mark R., Bhandari, Ramanath, Chang, Emmanuel Y., Haug, Sara J., London, Nikolas J. S., Mein, Luke, Sheth, Veeral S., Wolfe, Jeremy D., Singer, Michael A., Danzig, Carl J.
Publicado 2023

One-Year Follow-Up in a Phase 1/2a Clinical Trial of an Allogeneic RPE Cell Bioengineered Implant for Advanced Dry Age-Related Macular Degeneration

por Kashani, Amir H., Lebkowski, Jane S., Rahhal, Firas M., Avery, Robert L., Salehi-Had, Hani, Chen, Sanford, Chan, Clement, Palejwala, Neal, Ingram, April, Dang, Wei, Lin, Chih-Min, Mitra, Debbie, Pennington, Britney O., Hinman, Cassidy, Faynus, Mohamed A., Bailey, Jeffrey K., Mohan, Sukriti, Rao, Narsing, Johnson, Lincoln V., Clegg, Dennis O., Hinton, David R., Humayun, Mark S.
Publicado 2021

Survival of an HLA-mismatched, bioengineered RPE implant in dry age-related macular degeneration

por Kashani, Amir H., Lebkowski, Jane S., Hinton, David R., Zhu, Danhong, Faynus, Mohamed A., Chen, Sanford, Rahhal, Firas M., Avery, Robert L., Salehi-Had, Hani, Chan, Clement, Palejwala, Neal, Ingram, April, Dang, Wei, Lin, Chih-Min, Mitra, Debbie, Martinez-Camarillo, Juan Carlos, Bailey, Jeff, Arnold, Cassidy, Pennington, Britney O., Rao, Narsing, Johnson, Lincoln V., Clegg, Dennis O., Humayun, Mark S.
Publicado 2022